[Today's Focus]

Alibaba-W (09988.HK) still has a repurchase capacity of 20.7 billion dollars under the share repurchase plan.

Alibaba-W (09988.HK) announced that, during the quarter ending December 31, 2024, the company repurchased a total of 0.119 billion ordinary shares for a total price of 1.3 billion USD (equivalent to 15 million American depositary shares). These repurchases were conducted on the U.S. market according to the company's share repurchase program.

As of December 31, 2024, the company had 18.517 billion shares of common stock outstanding (equivalent to 2.315 billion American depositary shares). Compared to September 30, 2024, there was a net decrease of 0.103 billion shares of common stock, with a net decrease ratio of 0.6% (after accounting for shares issued under the Stock-based Incentive plan).

As of December 31, 2024, the company still had a buyback capacity of 20.7 billion USD under the Board of Directors authorized stock buyback plan, valid until March 2027.

[Significant Events]

CNQC INT'L (01240.HK) has been awarded a construction contract with a total contract value expected to be approximately 1.896 billion HKD.

GOFINTECH INNOV (00290.HK) has signed a Global Strategy cooperation agreement with Lingxuan Technology.

HAITONG SEC (06837.HK): GTJA plans to absorb and merge HAITONG SEC through a stock exchange and raise matching funds, and this matter will be submitted for approval.

Operating Data:

In December, Xiaopeng Autos (09868.HK) delivered a total of 36,695 smart electric vehicles, a year-on-year increase of 82%.

Qinhuangdao Port (03369.HK) has a total throughput of 0.414 billion tons in 2024, a year-on-year increase of 5.66%.

[Pharmaceutical Innovation]

CSPC PHARMA (01093.HK): SYS 6010 has received breakthrough therapy designation in China.

ZHAOKE OPHTH-B (06622.HK): The National Medical Products Administration has accepted the simplified new drug application for NVK002, used for treating progressive myopia in children.

GRANDPHARMA (00512.HK): The registration clinical study of a Global innovative temperature-sensitive embolic agent in China has completed the enrollment of the first patient.

FOSUN PHARMA (02196.HK): Application for the registration of injectable Letrozole has been accepted.

MABPHARM-B (02181.HK): The Pakistan Drug Regulatory Authority has approved the registration of the core product CMAB008 (Injectable Infliximab).

[Acquisitions and Sales]

CGN MINING (01164.HK): The original holding of 11.26% equity in Fission has been fully converted into 2.61% equity in Paladin.

LAI SI ENT (02266.HK) plans to acquire a Hong Kong property for 10.36 million HKD.

ASIA ENERGY LOG (00351.HK) sold a total of 13.616 million shares of Haotian for 9.434 million Hong Kong dollars.

Stock-Based Incentive:

VALUE PARTNERS (00806.HK): Lin Xianghong has been appointed as the Chairman of the Board of Directors and has granted a total of 42.9277 million stock options.

YESASIA HLDGS (02209.HK) granted 2 million stock options.

WYNN MACAU (01128.HK) granted 0.928 million shares as reward shares.

[Rights Issue]

FB MINING (02212.HK) intends to conduct a placement at a discount of approximately 14.73% for up to 0.21 billion shares, raising about 22.52 million Hong Kong dollars.

[Repurchase and Cancellation]

S.F. Holding (06936.HK) has repurchased a total of 20.77 million shares of the company's A-shares.

TENCENT (00700.HK) spent 0.7 billion Hong Kong dollars to repurchase 1.68 million shares on January 2.

ANTA SPORTS (02020.HK) repurchased 1.3 million shares on January 2 for 99.527 million Hong Kong dollars.

AIA (01299.HK) spent HKD 62.33 million to repurchase 1.128 million shares on January 2.

KUAISHOU-W (01024.HK) spent 58.84 million Hong Kong Dollars on January 2 to repurchase 1.447 million shares.

HSBC Holdings (00005.HK) spent 46.847 million HKD to repurchase 0.6172 million shares on December 31.

CSPC PHARMA (01093.HK) spent HKD 29.4259 million to repurchase 6.3 million shares on January 2.

TIMES ELECTRIC (03898.HK) spent 13.5235 million Hong Kong Dollars on January 2 to repurchase 0.425 million shares.

STANCHART (02888.HK) spent 3.32 million British Pound to repurchase 0.335 million shares on December 31.

SAMSONITE (01910.HK) spent HKD 11.34 million to repurchase 0.515 million shares on January 2.

AAC TECH (02018.HK) spent 11.5184 million Hong Kong dollars to repurchase 0.314 million shares on January 2.

Wanzhi Cloud (02602.HK) spent 10.2 million HKD to repurchase 0.5 million shares on January 2.